<DOC>
	<DOC>NCT01622946</DOC>
	<brief_summary>The effects of topical application of 3g tranexamic acid for 2 hours prior to opening of the suction drain following a total hip replacement</brief_summary>
	<brief_title>The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty Through the Direct Anterior Approach</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postoperative Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>patients who will receive a unilateral total hip arthroplasty coagulopathy allergy to tranexamic acid preoperative anemia (a hemoglobin value of &lt; 11g/dL in females and &lt; 12g/dL in males) fibrinolytic disorders a history of arterial or venous thromboembolic disease pregnancy breastfeeding major comorbidities</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>total hip arthroplasty</keyword>
	<keyword>tranexamic acid</keyword>
	<keyword>postoperative blood loss</keyword>
</DOC>